The Israel Institute for Biological Research’s vaccine developed against possible use of anthrax may be stricken with several unidentified problems. Senior staff members claim that their warnings regarding problems with the product were ignored by the institute director and one of the complainants, a senior manager, demoted. The vaccine against anthrax, which affects the respiratory system, began development shortly following the 1991 Gulf War and it was reported by 2001 that a vaccine was ready.
The Institute, located in Nes Tziona south of Tel Aviv, is considered one of the most secret in Israel and falls under the direct control of the Prime Minister’s Office. Foreign sources report that it conducts research and development on and to protect against chemical and biological weapons.